Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mattsson

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Thrombosis Research|May 1, 1993
A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinaseK Wikström, C Mattsson, G Pohl
The Annals of Otology, Rhinology, and Laryngology|August 1, 1995
Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Experimental studyC Mattsson, K Magnuson, S Hellström
Thrombosis Research|May 1, 1983
Effect on haemostasis of intravenous injection of alpha 2-antiplasmin in cats treated with streptokinaseM Einarsson, C Mattsson, S Nilsson
Scandinavian Journal of Immunology|January 1, 1975
Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravisJ A Aarli, C Mattsson, E Heilbronn
The Annals of Otology, Rhinology, and Laryngology|June 1, 1997
Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosisC Mattsson, S L Marklund, S Hellström
Acta Anaesthesiologica Scandinavica|February 11, 2000
Effects of melagatran, an inhibitor of thrombin, on fibrin deposits, haemodynamics, and platelet count in endotoxaemic pigsM Eriksson, T Saldeen, C Mattsson, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Antithrombotic effects of heparin oligosaccharidesC Mattsson, M Palm, K Söderberg, et al.
Thrombosis and Haemostasis|December 30, 1998
Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pigM Eriksson, A Larsson, T Saldeen, et al.
Thrombosis Research|June 1, 1986
Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant womenL Häggroth, C Mattsson, P Felding, et al.
Thrombosis and Haemostasis|August 13, 1990
Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activityM Palm, C Mattsson, C M Svahn, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Thrombosis Research|May 1, 1993
A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinaseK Wikström, C Mattsson, G Pohl
The Annals of Otology, Rhinology, and Laryngology|August 1, 1995
Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Experimental studyC Mattsson, K Magnuson, S Hellström
Thrombosis Research|May 1, 1983
Effect on haemostasis of intravenous injection of alpha 2-antiplasmin in cats treated with streptokinaseM Einarsson, C Mattsson, S Nilsson
Scandinavian Journal of Immunology|January 1, 1975
Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravisJ A Aarli, C Mattsson, E Heilbronn
The Annals of Otology, Rhinology, and Laryngology|June 1, 1997
Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosisC Mattsson, S L Marklund, S Hellström
Acta Anaesthesiologica Scandinavica|February 11, 2000
Effects of melagatran, an inhibitor of thrombin, on fibrin deposits, haemodynamics, and platelet count in endotoxaemic pigsM Eriksson, T Saldeen, C Mattsson, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Antithrombotic effects of heparin oligosaccharidesC Mattsson, M Palm, K Söderberg, et al.
Thrombosis and Haemostasis|December 30, 1998
Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pigM Eriksson, A Larsson, T Saldeen, et al.
Thrombosis Research|June 1, 1986
Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant womenL Häggroth, C Mattsson, P Felding, et al.
Thrombosis and Haemostasis|August 13, 1990
Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activityM Palm, C Mattsson, C M Svahn, et al.
Pageof 5